Strategies For Periodontal Risk Assessment and Prognosis
Strategies For Periodontal Risk Assessment and Prognosis
Strategies For Periodontal Risk Assessment and Prognosis
Early detection and proper management of periodontal disease can help patients maintain
their natural dentition.
By Yusuke Hamada, DDS, MSD, Takaaki Kishimoto, DDS, PhD, Hawra Alqallaf, DDS and Vanchit John,
BDS, MDS, DDS, MSD On Aug 25, 2017
Early detection and proper management of periodontal disease can help patients maintain their
natural dentition
PURCHASE COURSE
This course was published in the September 2017 issue and expires September 2020. The authors
have no commercial conflicts of interest to disclose. This 2 credit hour self-study activity is
electronically mediated.
OBJECTIVES
After reading this course, the participant should be able to:
1. Explain the various periodontal prognosis systems, as well as risk factors affecting
treatment and prognoses.
2. Discuss the prevalence of peri-implant disease, and treatments that can improve a tooth’s
prognosis.
3. Detail the challenges in establishing an absolute prognostic value for periodontal patients.
Determining a tooth’s prognosis is a critical step in patient care that is established after a
diagnosis has been made, but before treatment has been planned and presented. Because
periodontal disease is a multifactorial condition, establishing a periodontal prognosis involves
both art and science. Further complicating matters, periodontal prognostic outcomes also depend
on the individual’s risk factors and his or her compliance with biofilm control. With the goal of
improved outcomes, this article will review the literature surrounding classification systems that
can be used to assess periodontal prognosis.
Although dental implants represent a viable solution for many patients with periodontally
compromised dentition, these are not necessarily lifelong restorations. Peri-implant mucositis and
peri-implantitis are common complications following implant placement. Derks and
Tomasi1 reported the prevalence of peri-implant mucositis and peri-implantitis at 19% to 65%.
These are the most common pathological conditions that lead to soft- and hard-tissue loss around
implants and compromise the functional and esthetic outcome of implant therapy.
Growing recognition that implants are not a panacea for either full or complete edentulism has led
to renewed interest in saving teeth by using established therapies to improve the periodontal
prognosis. Assuming they are supported by appropriate maintenance, the literature indicates that
high survival and success rates can be achieved with compromised teeth. 2–4 Early detection and
proper management of periodontal conditions are critical to successful outcomes. Toward this
goal, identifying the prognosis of each tooth — as well as systemic and local risk factors for
disease progression — are critical during active periodontal treatment and supportive periodontal
therapy (SPT).
PERIODONTAL PROGNOSIS
According to The Merriam-Webster Dictionary, “Prognosis” is defined as “the prospect of
recovery as anticipated from the usual course of disease or peculiarities of the case.” In medicine,
however, the term is commonly defined by the mortality rate. Although many periodontal
prognosis systems have been developed, most of the prognoses are based on tooth mortality (i.e.,
extractions).5–8 Assigning an accurate prognosis for each tooth benefits patients and clinicians by
providing information on whether proposed periodontal and restorative treatment promises the
likelihood of a successful long-term outcome. That said, in this era of evidence-based dentistry,
there is no gold standard for periodontal prognosis tools. Because disease progression is affected
by many factors — including systemic conditions, local influences and the practitioner’s skill
level — it is virtually impossible to establish an absolute prognostic value. Accordingly, Samet
and Jotkowitz9 introduced the term “relative prognostic value.” The idea is to help practitioners
identify teeth that appear to have a more favorable treatment outcome, as opposed to those more
severely compromised by disease.
Among the various periodontal prognosis systems, the one most widely used was proposed by
McGuire and Nunn in 1996.6 It consists of five categories that include good, fair, poor,
questionable and hopeless (Table 1). In this system, clinicians assign each tooth to a category
based on their ability to control the etiology of disease, attachment loss, presence of furcation
involvement, crown/root ratio, and the degree of tooth mobility. Over five years, the researchers
evaluated the accuracy of prognostic values in 100 periodontal patients. Prognostic categories
were assigned following active periodontal therapy and prior to initiating the SPT phase. The
study demonstrated that prognostic values are not stable over time, especially for teeth that are
categorized as fair, poor or questionable; in fact, only 50% of teeth assigned into one of these
three prognoses remained in the same category during subsequent assessments.
FIGURE
1A. Clinical view of localized severe chronic periodontitis on tooth #23.
The authors identified possible clinical factors that led to the altering of the initially assigned
prognosis. These included smoking, diabetes, probing depth, furcation involvement and
parafunctional habits. One of the study’s limitations was that regenerative treatment — such as
guided tissue regeneration and the utilization of growth factors around teeth — was not
performed. In periodontal patients, it is well established that regenerative procedures on certain
defects can lead to bone fill and clinical attachment level gain, and thus improve a tooth’s
prognosis (Figures 1A and 1B and Figures 2A and 2B). 10,11 Another limitation was the
classification utilized teeth mortality, which is usually determined (and affected) by the clinician
and his or her treatment philosophy.
FIGURE 1B.(Left)Radiograph of tooth #23 from the patient in Figure 1A, with evidence of
vertical bone defect. FIGURES 2A (Center) and 2B (Right). Clinical (A) and radiographic
(B) views of #23 one year after guided tissue regeneration with demineralized freeze-dried bone
allograft and amnionchorion membrane.
In order to account for these limitations, Kwok and Caton 12 proposed a prognosis system based on
future periodontal stability with treatment (Table 2). Unlike McGuire’s and Nunn’s classification,
Kwok’s and Caton’s model focuses on how periodontal disease activity is suppressed by
controlling systemic and local factors. These include patient compliance, smoking status and
diabetic conditions as general factors, with deep probing depth, plaque retentive factors, mobility
and trauma from occlusion considered as local factors. As is evident from these classifications,
periodontal prognosis is dynamic because systemic and local risk factors are not permanent
conditions. For example, glycemic control in a patient with diabetes might worsen during the
periodontal maintenance phase, possibly contributing to progression of periodontal disease.
Conversely, the prognosis of each tooth might improve if a patient quits smoking.
Lang and Tonetti21 introduced a Periodontal Risk Assessment (PRA) model that evaluates the risk
of periodontal breakdown based on a combination of six parameters: percentage of BOP, total
sites of residual pockets > 5 mm, number of teeth lost, bone loss in relation to the patient’s age,
systemic/genetic condition, and environmental factors (e.g., smoking status). This tool is used to
assess risk following active periodontal therapy and prior to SPT. It does not require any specific
formula to calculate risk and is easy to fill out chairside. In addition, it is relatively easy to
visualize the degree of risk. However, this system has several disadvantages. Because clinicians
initiate PRA after active periodontal therapy, for example, this tool is not a good indicator for
treatment planning or active periodontal therapy. In addition, while the six parameters have been
shown to be major risk factors, patient compliance and local plaque-retentive factors are not
included in the criteria.
In a retrospective study, Matuliene et al 22 evaluated the validity of PRA with 160 patients for an
average of 9.5 years. Based on the PRA system, all subjects were assigned to low-, moderate- or
high-risk profile following active periodontal therapy. Most patients with low and moderate risk
had a twice-yearly recall interval, while more than half of the high-risk patients were seen three to
four times per year. During the SPT phase, 2.59 teeth per patient were lost in the high-risk group;
by comparison, 1.02 teeth per patient were lost in the moderate-risk group, while the low-risk
patients lost an average of 1.18 teeth. Based on this study, if a patient is categorized in the high-
risk group, a standard three- or four-month recall might not prove sufficient to prevent future
breakdown of periodontal tissue. Thus, recall intervals should be based on disease activity,
residual risk factors and patient compliance — not on insurance coverage.
As noted, there is no gold standard in periodontal risk assessment tools because there are
advantages and disadvantages to each system. The goal of using an assessment tool is to provide
more predictable care and facilitate communication between dental teams and specialists.
Although periodontal risk evaluation is a powerful tool for periodontal and restorative treatment,
it must be appreciated that caries, endodontic failures, fractured teeth and similar conditions also
affect a patient’s prognosis. Risk assessment and prognosis systems need to account for these
conditions as well.
Technological advances also allow clinicians to utilize noninvasive methods — such as salivary
biomarker tests — to assess periodontal conditions. Various host-related cytokines and
biomarkers have been detected in the progression of periodontal disease. Studies have shown a
positive relationship between salivary biomarkers and the severity of periodontitis, 23,24 and, unlike
a blood examination, saliva collection does not require any special training. Thus, it appears that
salivary tests can be used in the diagnosis of periodontal disease and to better understand risk
assessment. In addition, disease stability during maintenance can be monitored, along with the
evaluation of treatment outcomes. In the future, personalized therapy that includes salivary
examination seems likely to improve the quality of periodontal care. 25
PRACTICE RECOMMENDATIONS
Although this article has emphasized the importance of risk analysis, specific guidelines for
periodontal treatment — including the timing of referral to a specialist — are challenging due to
the disease’s multifactorial nature. In a study of periodontal status, treatment, and when patients
were referred to periodontists, Dockter et al 26 found that among 100 newly referred patients, 74%
were diagnosed with severe periodontitis and needed to have teeth extracted due to the severity of
disease. This suggests that diagnosis, treatment and timely referral to a specialist were not
satisfactory.
At the time of initial examination, during nonsurgical periodontal treatment and throughout SPT,
clinicians need to consider the risks of disease development and possible need for referral.
Although many periodontal patients can be managed appropriately by general practitioners, there
is no single best treatment for every patient. Accordingly, the authors of this paper propose
instructions that clinicians can use in referral decisions (Table 4). These are intended to foster a
multidisciplinary approach with the goal of improved care.
3. Fugazzotto PA. A comparison of the success of root resected molars and molar position
implants in function in a private practice: results of up to 15-plus years. J Periodontol.
2001;72:1113–1123.
4. Giannobile WV, Lang NP. Are dental implants a panacea or should we better strive to
save teeth? J Dent Res. 2016;95:5–6.
5. Becker W, Berg L, Becker BE. The long term evaluation of periodontal treatment and
maintenance in 95 patients. Int J Periodontics Restorative Dent. 1984:4;54–71.
6. McGuire MK, Nunn ME. Prognosis versus actual outcome. II. The effectiveness of
clinical parameters in developing an accurate prognosis. J Periodontol. 1996;67:658–665.
8. Miller PD Jr, McEntire ML, Marlow NM, Gellin RG. An evidenced-based scoring index
to determine the periodontal prognosis on molars. J Periodontol. 2014;85:214–225.
11. Reynolds MA, Kao RT, Camargo PM, et al. Periodontal regeneration — intrabony
defects: a consensus report from the AAP Regeneration Workshop. J Periodontol.
2015;86(Suppl 2):S105–S107.
12. Kwok V, Caton JG. Commentary: prognosis revisited: a system for assigning periodontal
prognosis. J Periodontol. 2007;78:2063–2071.
13. Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of
progression and regression of advanced destructive periodontal disease. J Clin
Periodontol. 1982;9:472–481.
14. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive
periodontal disease. J Clin Periodontol. 1984;11:21–32.
15. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary
of current work. Lab Invest. 1976;34:235–249.
16. Löe H, Anerud A, Boysen H, Morrison E. Natural history of periodontal disease in man.
Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J
Clin Periodontol. 1986;13:431–445.
19. Page RC, Krall EA, Martin J, Mancl L, Garcia RI. Validity and accuracy of a risk
calculator in predicting periodontal disease. J Am Dent Assoc. 2002;133:569–576.
20. Page RC, Martin JA. Quantification of periodontal risk and disease severity and extent
using the Oral Health Information Suite (OHIS). Periodontal Pract Today. 2007;4:163–
180.
21. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive
periodontal therapy (SPT). Oral Health Prev Dent. 2003;1:7–16.
22. Matuliene G, Studer R, Lang NP, et al. Significance of periodontal risk assessment in the
recurrence of periodontitis and tooth loss. J Clinl Periodontol. 2010;37:191–199.
23. Salminen A, Gursoy UK, Paju S, et al. Salivary biomarkers of bacterial burden,
inflammatory response, and tissue destruction in periodontitis. J Clin Periodontol.
2014;41:442–450.
24. Korte DL, Kinney J. Personalized medicine: an update of salivary biomarkers for
periodontal diseases. Periodontol 2000. 2016;70:26–37.
25. Giannobile WV, Salivary diagnostics for periodontal diseases. J Am Dent Assoc.
2012;143(Suppl 10):6S–11S.
26. Dockter KM, Williams KB, Bray KS, Cobb CM. Relationship between prereferral
periodontal care and periodontal status at time of referral. J Periodontol. 2006;77:1708–
1716.